SUBSCRIBERS

Taking a new path in pain management (Amended)

iX Biopharma wants to be the first in the world to get ketamine registered in the US as an alternative to opioid - the only pain management drug administered by doctors.

Published Sun, Jul 19, 2015 · 09:50 PM

iX Biopharma

Singapore

WITH one day to go before it trades on the Catalist, late-stage specialty pharmaceutical firm iX Biopharma has already caught the eyes of interested parties.

This might have something to do with the firm's niche, which lies in the development and commercialisation of innovative therapies for pain management and male erectile dysfunction.

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes